457
Views
100
CrossRef citations to date
0
Altmetric
Original Article

Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: A study using positron emission tomography (PET)

, , , , , & show all
Pages 471-479 | Received 25 May 2004, Accepted 20 Sep 2004, Published online: 03 Jul 2009

References

  • Kraus JF, McArthur DL. Incidence and prevalence of, and costs associated with, traumatic brain injury. In: Rosenthal M, Griffith ER, Kreutzer JS, editors. Rehabilitation of the adult and child with traumatic brain injury, 3rd edn. Philadelphia, PA: FA Davis; 1998. pp. 3–18.
  • Levin HS, Williams DH, Eisenberg HM, High WM Jr, Guinto FC. Serial magnetic resonance imaging and neurobehavioral findings after mild to moderate closed head injury. Journal of Neurology Neurosurgery and Psychiatry 1992; 55:255–62.
  • Levin H, Kraus MF. The frontal lobes and traumatic brain injury. Journal of Neuropsychiatry and Clinical Neurosciences 1994;6:443–54.
  • Sosin D, Sniezek JE, Waxweiller RJ. Trends in death associated with traumatic brain injury, 1979 through 1992: Success and failures. Journal of the American Medical Association 1995;272: 1778–80.
  • Eker C, Schalen W, Asgeirsson B, Grande PO, Nordstrom CH. Reduced mortality after severe head injury will increase the demands for rehabilitation services. Brain Injury 2000; 14:605–19.
  • Adams JH, Graham DI, Scott G, Parker LS, Doyle D. Brain damage in fatal non-missile head injury. Journal of Clinical Pathology 1980;33:1132–45.
  • Povlishok J. Traumatically induced axonal injury: Pathogenesis and pathobiological implications. Brain Pathology 1992; 2:1–12.
  • Hammill RW, Woolf PD, McDonald JV, Lee LA, Kelly M. Catecholamines predict outcome in traumatic brain injury. Annals of Neurology 1987;21:438–43.
  • McIntosh TK, Yu T, Gennarelli TA. Alterations in regional brain catecholamine concentrations after experimental brain injury in the rat. Journal of Neurochemistry 1994;63:1426–33.
  • Yan HQ, Kline AE, Ma X, Hooghe-Peters EL, Marion DW. Tyrosine hydroxylase, but not dopamine beta-hydroxylase, is increased in rat prefrontal cortex after traumatic brain injury. Neuroreport 2001;12:2323–7.
  • Donnemiller E, Brenneis C, Wissel J, Scherfler C, Poewe W, Riccabona G, Wenning GK. Impaired dopaminergic neuro-transmission in patients with traumatic brain injury: A SPECT study using 123I-beta-CIT and 123I-IBZM. European Journal of Nuclear Medicine 2000;27: 1410–4.
  • Hoofien D, Gilboa A, Vakil E, Donovick PJ. Traumatic brain injury (TBI) 10-20 years later: A comprehensive study of psychiatric symptomatology, cognitive abilities and psycho-social functioning. Brain Injury 2001;15:189–209.
  • Baldo JV, Shimamura AP, Delis DC, Kramer J, Kaplan E. Verbal and design fluency in patients with frontal lobe lesions. Journal of the International Neuropsychological Society 2001;7:586–96.
  • Gronwall D. Cumulative and persisting effects of concussion on attention and cognition. In: Levin HS, Eisenberg HM, Benton AL, editors. Mild brain injury. New York: Oxford University Press; 1989. pp. 153–62.
  • Levin HS, Amparo E, Eisenberg HM, Williams DH, High WM Jr, McArdle CB, Weiner RL. Magnetic resonance imaging and computerized tomography in relation to the neurobehavioral sequelae of mild and moderate head injuries. Journal of Neurosurgery 1987;66:706–13.
  • Christodoulou C, DeLuca J, Ricker JH, Madigan NK, Bly BM, Lange G, Kalnin AJ, Liu WC, Steffener J, Diamond BJ, Ni AC. Functional magnetic resonance imaging of working memory impairment after traumatic brain injury. Journal of Neurology Neurosurgery and Psychiatry 2001;71:161–8.
  • Herrman EC, Grabliks J, Engle C, Perlman PL. Antiviral activity of L-adamantanamine (amantadine). Proceedings of the Society of Experimental Biology and Medicine 1960;103:625.
  • Schwab RS, England AC, Poskanzer DC, Poskanzer DC, Young RR. Amantadine in the treatment of Parkinson's disease. Journal of the American Medical Association 1969;208:1168–70.
  • Winblad B, Poritis N. Memantine in severe dementia: Results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine). International Journal of Geriatric Psychiatry 1999;14:135–46.
  • Aoki FY, Sitar DS. Clinical pharmacokinetics of amantadine hydrochloride. Clinical Pharmacokinetics 1988;14:35–51.
  • Moresco RI\4, Volonte MA, Messa C, Gobbo C, Galli L, Carpinelli A, Panzacchi A, Franceschi M, Fazio F. New perspectives on neurochemical effects of amantadine in the brain of parkinsonian patients: A PET-[(11)C]raclopride study. Journal of Neural Transmission 2002;109: 1265–74.
  • Gianutsos G, Chute S, Dunn JP. Pharmacological changes in dopaminergic systems induced by long-term administration of amantadine. European Journal of Pharmacology 1985; 110:357–61.
  • Deep P, Dagher A, Sadikot A, Gjedde A, Cumming P. Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antago-nism with a low dose of amantadine. Synapse 1999;34: 313–8.
  • Kegeles LS, Martinez D, Kochan LD, Hwang Y, Mawalawi O, Sucklow RF, van Heertum RL,, Laurelle M. NMDA antagonist effects on striatal dopamine release: Positron emission tomography studies in humans. Synapse 2002;43:19–29.
  • Hesselink MB, DeBoer AG, Breimer DD, Danysz W. Dopamine release in the prefrontal cortex in response to memantine following sub-chronic NMDA receptor blockade with memantine: A microdialysis study in rats. Journal of Neural Transmission 1999;106:803–18.
  • Goldman P. Functional development of the prefrontal cortex in early life and the problem of neuronal plasticity. Experimental Neurology 1971;32:366–87.
  • Chugani H, Phelps M. Imaging human brain development with positron emission tomography. Journal of Nuclear Medicine 1991;32:23–6.
  • Passler M, Isaac W, Hynd G. Neuropsychological development of behavior attributed to frontal lobe functioning in children. Developmental Neuropsychology 1985;1:349–70.
  • Dixon CE, Kraus MF, Ma X, Yan HQ, Griffith RG, Wolfson BM, Marion DW. Amantadine improves water maze perfor-mance following traumatic brain injury in rats. Restorative Neurology and Neuroscience 1999;14:285–94.
  • Gualtieri T, Chandler M, Coons TB, Brown LT. Amantadine: A new clinical profile for traumatic brain injury. Clinical Neuropharmacology 1989;12:258–170.
  • Andersson S, Berstad J, Finset A. Amantadine in cognitive failure in patients with traumatic head injuries. Tidsskrift for Den Norske Laegeforening 1992;112:2070–2.
  • Nickels JL, Schneider WN, Dombovy ML, Wong JM. Clinical use of amantadine in brain injury rehabilitation. Brain Injury 1994;8:709–18.
  • Kraus MF, Maki PM. The effect of amantadine hydrochloride on neuropsychiatric sequelae of brain injury: Case studies and review. Journal of Neuropsychiatry and Clinical Neurosciences 1997;9:222–30.
  • Gross H, Kling A, Henry G, Herndon C, Lavretsky H. Local cerebral glucose metabolism in patients with long term behavioral and cognitive deficits following mild traumatic brain injury. Journal of Neuropsychiatry 1996;8:324–34.
  • Abdel-Dayem HM, Abu-Judeh H, Kumar M, Atay S, Naddaf S, El-Zeftaway H, Luo JQ. SPECT brain perfusion abnormalities in mild or moderate traumatic brain injury. Clinical Nuclear Medicine 1998;23:309–17.
  • Abu-Judeh H, Singh M, Mardeu J, Abdel-Dayem H. Discordance between FDG uptake and technetium-99m HMPAO brain perfusion in acute traumatic brain injury. Journal of Nuclear Medicine 1998;39: 1357–9.
  • War Department, Adjutant General's Office. Army individual test battery. Washington, DC: War Department, Adjutant General's Office; 1944.
  • Conners CK. Conners' continuous performance test-II technical guide and software manual. North Tonawanda, NY: Multi-Health Systems, Inc.; 2000.
  • Benton AL, Hamsher K, Sivan AB. Multilingual aphasia exam. Iowa City, IA: AJA Associates; 1994.
  • Delis DC, Kramer JH, Kaplan E, Ober BA. California verbal learning test second edition-adult version manual. San Antonio, TX: The Psychological Corporation; 2000.
  • Benton AL, Sivan AB, Hamsher K, Varney NR, Spreen O. Contributions to neuropsychological assessment-a clinical manual. New York: Oxford University Press, Inc.; 1994.
  • Smith GS, Schloesser R, Brodie JD, Dewey SL, Logan J, Vitkun SA, Simkowitz P, Hurley A, Cooper T, Volkow ND, Cancro R. Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects. Neuropsychopharmacology 1998;18: 18–25.
  • Friston KJ. Commentary and opinion: II Statistical parametric mapping: Ontology and current issues. Journal of Cerebral Blood Flow Metabolism 1995;15:361–70.
  • Logan J, Fowler JS, Volkow ND, Ding YS, Wang GJ, Alexoff DL. A strategy for removing the bias in the graphical analysis method. Journal of Cerebral Blood Flow Metabolism 2001;21:307–20.
  • Blanpied TA, Boeckman FA, Aizenman E, Johnson JW. Trapping channel block of NMDA-activated responses by amantadine and memantine. Journal of Neurophysiology 1997;77:309–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.